Medicis Says Genzyme Corporation Sues For Patent Infringment

Oct 20 (Reuters) - Medicis Pharmaceutical Corp (MRX.N) said Genzyme Corp (GENZ.O) had sued it in a U.S. court over its wrinkle treatments, accusing Medicis of patent violation.

MORE ON THIS TOPIC